EMUs: Enhanced Monitoring Using Sensors After Surgery
Launched by UNIVERSITY OF EDINBURGH · Aug 19, 2024
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
The EMUs trial, which stands for Enhanced Monitoring Using Sensors After Surgery, is studying how wearable wireless sensors can help doctors notice if patients are getting worse after surgery. These sensors will be placed on the chest and fingers of patients who are having major surgery, and they will track vital signs like heart rate and oxygen levels for up to 10 days. The goal is to see if this data can help predict any complications early on. This study is taking place in various countries, including the UK, India, and Mexico, and aims to improve patient care by using technology.
To participate in this trial, individuals need to be at least 18 years old and scheduled for major surgery that involves a cut of 5 cm or more. Those with allergies to adhesive dressings or who are pregnant cannot participate. It's important to note that this study is observational, meaning it will only collect data without changing any current patient care practices. Participants will wear the sensors for monitoring, and their data will be used to help develop better ways to detect any health issues after surgery.
Gender
ALL
Eligibility criteria
- Participant Inclusion Criteria:
- • Adults 18 years and older.
- • Undergoing an elective or emergency major surgery procedure with a planned skin incision of 5 cm or greater. Any indication for surgery can exist, including benign, malignant, and trauma.
- • Willing and able to provide written informed consent.
- Participant Exclusion Criteria:
- • Those under the age of 18.
- • A documented or suspected allergy to adhesive dressings.
- • Obstetric patients
- • Unwilling or unable to provide written informed consent.
About University Of Edinburgh
The University of Edinburgh, a prestigious institution renowned for its commitment to research excellence and innovation, serves as a leading clinical trial sponsor dedicated to advancing healthcare through rigorous scientific inquiry. With a strong emphasis on multidisciplinary collaboration, the university facilitates cutting-edge clinical studies that aim to explore novel therapies and improve patient outcomes. Leveraging its extensive network of researchers, healthcare professionals, and state-of-the-art facilities, the University of Edinburgh is at the forefront of translating scientific discoveries into practical applications, thereby contributing significantly to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Edinburgh, , United Kingdom
Ikeja, , Nigeria
Lagos, , Nigeria
Tamale, , Ghana
Guatemala City, , Guatemala
Ludhiāna, , India
Veracruz, , Mexico
Ife, , Nigeria
Kigali, , Rwanda
Ouidah, Atlantique, Benin
Parakou, Borgou, Benin
Cotonou, Littoral, Benin
Porto Novo, Oeume, Benin
Berekum, Berekum East, Ghana
Techiman, Bono East, Ghana
Manali, Himachal Pradesh, India
Padhar, Madhya Pradesh, India
Ludhiāna, Punjab, India
Patients applied
Trial Officials
Ewen Harrison
Principal Investigator
University of Edinburgh
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported